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Abstract
Objectives: This study investigates how factors related to collection, storage,
transport time, and environmental conditions affect the quality and accuracy
of analyses of dried blood spot (DBS) samples.
Methods: Data come from the 2016 Health and Retirement Study (HRS) DBS
laboratory reports and the HRS merged with the National Climatic Data Center
(NCDC) Global Historical Climate Network Daily (NCDC GHCN-Daily) and the
NCDC Local Climatological Data, by zip code. We ran regression models to exam-
ine the associations between assay values based on DBS for five analytes (total cho-
lesterol, high-density lipoprotein (HDL) cholesterol, glycosylated hemoglobin
(HbA1c), C-reactive protein (CRP), and cystatin C) and the characteristics of DBS
cards and drops, shipping time, and temperature, and humidity at the time of
collection.
Results: We found cholesterol measures to be sensitive to many factors
including small spots, shipping time, high temperature and humidity. Small
spots in DBS cards are related to lower values across all analytes. Longer DBS
transit time before freezing is associated with lower values of total and HDL
cholesterol and cystatin C. Results were similar whether or not venous blood
sample values were included in equations.
Conclusions: Small spots, long shipping time, and exposure to high tempera-
ture and humidity need to be avoided if possible. Quality of spots and cards
and information on shipping time and conditions should be coded with the
data to make adjustments in values when necessary. The different results
across analytes indicate that results cannot be generalized to all DBS assays.
1 | INTRODUCTION
Dried blood spots (DBSs) have been used increasingly in
recent years as an alternative to traditional venous blood
collection in many large population studies (McDade,
Burhop, & Dohnal, 2004; McDade, Williams, & Snodgrass,
2007; Weir, 2008). This minimally invasive blood collection
method is relatively simple compared to conventional blood
sampling as it can be done by interviewers rather than med-
ically trained personnel (Amsterdam & Waldrop, 2010;
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Deep, Kumar, Kumar, & Thakkar, 2012). DBS samples may
also be easier to obtain as respondents are more likely to
agree to participate (Samuelsson et al., 2015; Williams &
McDade, 2009). Additional desirable features of this type of
blood collection include minimal requirements for transport
and storage (e.g., ambient temperature, no dry ice required,
no hazardous material regulations in shipping), and reduced
biohazard risks and contamination (Kulmatycki, Xu, &
Jarugula, 2014; Mei & Lee, 2014; Parker & Cubitt, 1999;
Zhang, Majumdar, Flarakos, & Tse, 2013). In general, blood
collection using this approach is simpler and less costly. It is
also thought that analytes in DBS samples can be preserved
for long periods without deterioration and DBS involves
lower cost than venous blood samples (VBSs) (Hannon &
Therrell, 2014).
While there are many advantages in DBS sampling,
conditions during the collection, shipping, handling, and
preanalytic phase such as the quality of the spots and
cards, time without freezing and atmospheric conditions
may have substantial influences on the validity of DBS
assays. For instance, smaller blood spots have been found
to yield lower results for all analytes, raising risks of signif-
icant negative biases with the use of DBS; and the effect of
multispotted samples rather than single spots differed
depending on the analyte (George & Moat, 2016). Length
of time before freezing may also affect the quality of DBS
assays. Enzyme activities in DBS have been found to show
considerable differences depending on storage method, the
use of desiccant, and the duration of shipping (Elbin et al.,
2011). Storage temperature is another factor that affects
the stability of the DBS samples; DBS samples stored at
20C showed significantly greater deterioration over a year
compared to samples stored at 4C or below 0C for the
same duration (Batterman & Chernyak, 2014). Multiple
freeze-thaw cycles have also been documented to cause
significant variations in lipid concentrations compared to
fresh samples (Zivkovic et al., 2009).
Environmental conditions at the time of collection
could also affect the values of DBS assays as DBS are suscep-
tible to high temperature and humidity (Zhang et al., 2013),
which can facilitate bacterial growth or enhance the rate of
analyte degradation (Quraishi, Jain, & Ambekar, 2013;
Sharma, Jaiswal, Shukla, & Lal, 2014). High temperature
has been documented to be particularly detrimental for
high-density lipoprotein (HDL) cholesterol (Halonen,
Zanobetti, Sparrow, Vokonas, & Schwartz, 2011). High
humidity and temperature appear to have an interactive
effect on analytes (Freer, 2005; García-Lerma et al., 2009).
Thomas et al. (2018) found that values for HbA1c collected
under field conditions in a large population study in Indo-
nesia, with an average temperature above 24C and humid-
ity of 70%, resulted in upwardly biased estimates of diabetes
compared to venous blood or DBS collected under
controlled clinic conditions. Vulnerability to degradation of
DBS assay values differs by analyte (McDade et al., 2007).
For instance, glycosylated hemoglobin (HbA1c) may yield
stable values after being stored at room temperature up to a
month (Buxton, Malarick, Wang, & Seeman, 2009),
whereas C-reactive protein (CRP) assayed from DBS
declines significantly after 2 weeks (McDade et al., 2004).
How multiple preanalytic factors affect the quality and
accuracy of DBS samples collected from large population-
based surveys and what analytes are affected by what con-
ditions have not been systematically examined. Most prior
studies have attempted to establish the stability criteria
focused on relatively small sample sizes, limited to one
analyte, or a specific environmental condition, rather than
examining how multiple factors associated with collection,
storage, transport, and environmental conditions affect
the quality of DBS samples used for multiple analytes
collected in large population samples. Determining guide-
lines for preanalytic factors is important in clarifying the
validity of DBS-derived biomarkers and advising studies
based on DBS collection.
The present study investigates how preanalytic factors
related to collection, storage, transport, and environmental
conditions affect the quality and accuracy of DBS samples
collected in homes in a nationally representative survey, the
Health and Retirement Study (HRS). We take advantage of
data from the HRS collected in 2016, when both DBS and
VBS were collected on a number of analytes in this large
nationally representative population. The availability of
analyte results based on VBS allows us to assume that we
have a value for the analyte that reflects the actual clinical
value; however, we recognize this is a strong assumption
given that there is variability over time in the real value of
these analytes and that the amount of variability may differ
across people. We investigate the links between DBS spot
size and quality, shipping time, and atmospheric conditions
on the day of collection on the DBS value of analytes while
controlling for the value found in venous blood taken an
average of 2 months later. We hypothesize that these factors
will affect the quality of DBS-derived biomarkers; and that
the effect will be differential by analyte. Our aim is to iden-
tify preanalytic factors that affect the quality of DBS sam-
ples to promote protocols that produce accurate values of
DBS-derived biomarkers.
2 | DATA AND METHODS
2.1 | Data
Data for this study come from the 2016 HRS, a nationally
representative survey of the US population over age 50 con-
ducted by the University of Michigan (Juster & Suzman,
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1995; Sonnega et al., 2014). HRS collected biomarkers from
DBS from a half sample every 4 years from 2006 to 2014
and for the other half sample every 4 years from 2008 to
2016. DBS samples have been assayed for total cholesterol,
HDL cholesterol, glycosylated hemoglobin (HbA1c),
cystatin C, and CRP since 2006 (Crimmins et al., 2013). In
2016, DBS samples were collected halfway through the
household interviews by trained interviewers by filling up
to 10 circles with blood droplets across two Whatman blood
spot cards. DBS cards were placed in a specially designed
cardboard box allowing airflow on all sides for a minimum
of 2 hours of drying time prior to shipment. The loaded
cardboard boxes were placed in foil pouches with desiccant
and then mailed directly to the Department of Laboratory
Medicine at the University of Washington in Seattle for
assay. On receipt, the lab staff in Washington coded the
quality and characteristics of the DBS cards. DBS cards
were stored at −70C prior to and after analysis. The DBS
HbA1c assay was performed on a Bio-Rad Variant II Hemo-
globin Testing System (Hercules, CA); assay performance
was verified via comparison to HbA1c values of DBS-
matched whole blood samples assayed on that instrument.
The DBS total cholesterol assay and the DBS HDL choles-
terol assay were developed in-house using FDA-cleared
reagents from Synermed International (Westfield, IN) and
Beckman Coulter (Brea, CA), respectively. CRP was mea-
sured in theDBS by an enzyme-linked immunosorbent assay
(ELISA) using FDA-cleared kits from Biocheck, Inc. (San
Francisco, CA). The performance of the DBS assays was veri-
fied via comparisons to the concentrations of total choles-
terol, HDL cholesterol, and CRP in DBS-matched plasma
samples assayed on a Beckman Coulter AU680 Clinical
Chemistry Analyzer. Cystatin Cwasmeasured in the DBS by
ELISA using INSTAND e.V.-certified (Düsseldorf, Germany)
kits from BioVendor (Brno, Czechia); assay performancewas
verified via comparison to cystatin C concentrations of DBS-
matched plasma samples assayed on that platform. Commer-
cial certified traceable referencematerials were used tomoni-
tor the performance of the DBS, blood and plasma assays.
In 2016, HRS collected VBS for the first time. All HRS
panel respondents who completed a core interview in the
2016 wave, except proxy respondents and those residing in
nursing homes, were asked to consent to a venous blood
draw. Venipuncture was performed in a separate home visit
by a trained phlebotomist approximately 2 months after the
initial visit when the DBS were collected. Fasting was rec-
ommended but not required; the fasting status of the donor
was noted. The serum separator tubes that contained the
samples used for this analysis were centrifuged in the field
before being shipped cold to the University of Minnesota
Advanced Research and Diagnostic Laboratory where they
were processed within 24 hours of arrival or within 48 hours
of collection for most respondents. About 92% of the samples
arrived at the lab within 24 hours of collection, 99% arrived
within 48 hours. Assays were performed on a Cobas 6000
manufactured by Roche. Additional details about the venous
blood collection, laboratory equipment, and assay protocol
are described elsewhere (Crimmins, Faul, Thyagarajan, &
Weir, 2017).
We restricted our sample to those who had both VBS
and DBS data where the DBS were collected between
April 1, 2016 and December 31, 2016. Because we used
the zip code of the respondent's home address to match
each person to weather conditions on the day of DBS col-
lection, our analytic sample only included individuals
with zip code information. These restrictions left us a
sample size of 4456 individuals.
We obtained temperature data from the National Cli-
matic Data Center (NCDC) Global Historical Climate Net-
work Daily (NCDC GHCN-Daily), which includes daily
temperature from approximately 6400 weather stations
across the United States. We used the NCDC Local Climato-
logical Data, which contain hourly relative humidity from
about 1600 locations across the country, to determine
humidity levels. Using ArcGIS we created map layers with
point locations representing the geographic locations of
weather and humidity stations. Next, we spatially joined
weather and humidity data to respondents by determining
the nearest station to the respondent using the zip code cen-
troid associated with the respondent's home address where
the DBS collection took place. We were unable to obtain
temperature or humidity information for 853 individuals
because there were no weather recordings available at the
nearest station on the date of DBS collection (this was pri-
marily due to DBS collections that occurred on weekends or
holidays). Our final analytic sample includes 3321 individ-
uals with slightly different sample sizes for each DBS analyte
depending on whether a valid result was obtained.
2.2 | Measures
2.2.1 | Biomarkers
Five biomarkers were assayed at the University of
Washington from DBS: total cholesterol, HDL cholesterol,
glycosylated hemoglobin (HbA1c), CRP, and cystatin
C. These analytes were also collected from VBS. Fasting
glucosewasmeasured fromVBS as an alternative toHbA1c.
2.2.2 | Characteristics of DBS cards and
individual blood spots
These were coded by laboratory personnel at the Univer-
sity of Washington. We included the four most frequently
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used card quality indicators: multiple drops per printed
circle, smeared drops/inconsistent absorption, not placing
the desiccant correctly for shipping, and overlapping blood
spots. Card quality was assessed by the laboratory upon
arrival and indicates the quality of the collection by the
survey interviewers. Among the spots on cards, the best
quality spots were chosen for the assays. Individual spots
used for punches for individual assays were also character-
ized as overlapping/smeared, and small in size. Small
spots are blood drops that do not fully fill the preprinted
circle on the Whatman 903 collection card used by HRS.
A full-sized drop is ≥1 cm in diameter or about 60 μL of
blood; a small spot is <1 cm in diameter, or about ≤40 μL
of blood. We also indicated the number of days between
collection in the field and receipt at the University of
Washington when they were placed in the freezer. We cat-
egorized the length of time spent out of the freezer as 0-2
days, 3 days, 4-5 days, 6-7 days, and 8+ days.
2.2.3 | Weather conditions
Daytime temperature ≥ 32.2C (90F) on the day of DBS
collection was categorized as high temperature. We used
the highest humidity from noon to 6 PM on the date of
collection to indicate the maximum humidity level the
DBS was exposed to. A humidity level equal to or greater
than 90% was categorized as high humidity.
2.3 | Statistical model
For each assay, we performed two linear regression
models relating the characteristics of DBS cards and
drops, to the DBS assay; for the second equation we also
controlled for the VBS value. We feel for four of the equa-
tions, the VBS value can be regarded as a reliable indica-
tor of the actual value of the assay. Because HbA1c was
obtained only from DBS but not VBS, we used the values
of glucose measured in serum in the equation estimating
HbA1c in DBS. HRS respondents were asked but not
required to fast before DBS collection. We restricted our
sample to those with a fasted VBS when estimating
HbA1c in DBS. All models were estimated in SAS 9.4.
3 | RESULTS
Descriptive information on potential factors that might
affect DBS values is presented in Table 1. Among the indi-
cators of card quality, about 29% had smeared drops and
about 20% had multiple drops and overlapping spots.
However, because the highest quality spots available were
chosen for the assays, overlapping or smeared spots
occurred in very few cases for these analytes; only about
3% in most analytes except HbA1c (0.4%). Small spots were
much more common; about one-quarter had small spots
for all analytes except for HbA1c (8.2%), which was gener-
ally based on the first spot. Maximum temperature on days
when DBS were collected ranged from 0F to 115F and
about 24% were collected on days when the temperature
reached 90F or higher. About 12.7% of the DBS samples
were collected on days with maximum humidity greater
than or equal to 90%. About 11% spent 0-2 days in transit
from interviewer to the University of Washington; while
20% spent 3 days, 39% spent 4-5 days and 20% spent
6-7 days. About 10% did not arrive to the lab for more than
a week.
TABLE 1 Percent of samples by characteristics related to
validity of DBS assays in the US Health and Retirement Study, 2016
(N = 3321)
Percent




Incorrectly placed desiccant 5.4













High temperature (≥90 F) 24.2
High humidity (≥90%) 12.7






Abbreviations: CRP, C-reactive protein; DBS, dried blood spot; HbA1c,
glycosylated hemoglobin; HDL, high-density lipoprotein.
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The mean values, SD, and the range of each bio-
marker for both DBS and VBS are presented in Table 2.
The raw values of DBS-based total and HDL cholesterol
were higher than those from VBS; while the values of
CRP and cystatin C were fairly similar to those of VBS,
as previously shown in Crimmins et al. (2014). Because
of these differences HRS provides both initial DBS
values and a value made by equating the distributions
to those found in the National Health and Nutrition
Examination Survey (NHANES) in the data distributed
to users.
Results from regression models are shown in Table 3.
Among all analytes, the occurrence of small spots was associ-
ated with lower values, though this was only true for HbA1c
when the value of glucose was controlled. The reduction was
greatest for total cholesterol (42.18 or 63% of a SD); and
TABLE 2 Mean values and range
of biomarkers based on DBS and VBS in
the US Health and Retirement
Study, 2016
Mean (SD) Range
DBS VBS DBS VBS
Total cholesterol (mg/dL) 274.9 (66.8) 190.2 (42.4) 36-524 61-496
HDL cholesterol (mg/dL) 61.8 (20.2) 57.8 (19.6) 10-189 20-187
HbA1c (%) 5.6 (0.6) – 4.1-17.1 –
Glucose (mg/dL) – 105.6 (33.6) – 49-411
CRP (mg/L) 3.6 (4.6) 3.7 (4.1) 0.1-20.0 0.2-20.0
Cystatin C (mg/L) 1.3 (0.5) 1.2 (0.5) 0.1-7.0 0.5-9.2
Abbreviations: DBS, dried blood spot; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; VBS,
venous blood sample.
TABLE 3 Coefficients from linear regression models estimating value of biomarker from DBS in the US Health and Retirement
Study, 2016
Total cholesterol HDL cholesterol CRP Cystatin C HbA1c
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Quality of DBS card
Multiple drops 9.89 7.53 0.04 −2.05 −0.12 −0.15 −0.09 −0.04 0.06 0.15*
Smeared drops −9.18* −6.18* −0.78 0.81 −0.09 −0.09 0.05 0.00 −0.02 −0.03
Overlapping spots −9.22 −6.15 −0.50 1.59 0.31 0.49 0.09 0.03 −0.08 −0.11
Incorrectly placed
desiccant
4.08 −0.89 −2.16 −0.81 0.11 −0.35 −0.01 0.01 0.06 −0.04
Quality of individual spots
Overlapping,
smeared spot
−3.64 −9.77 −1.42 −4.97* −0.12 −0.41 −0.11 −0.05 −0.12 0.19
Small spot −42.18* −39.96* −6.79* −10.07* −1.26* −0.94* −0.20* −0.21* 0.02 −0.09*
Days before freezing (DBS)
(ref = 0-2 days)
3 days 1.93 2.92 −0.21 −0.69 −0.33 −0.09 −0.01 −0.00 0.09* 0.08*
4–5 days −5.90 −4.75 −2.48* −1.75 0.08 0.14 −0.00 −0.03 0.06 0.08*
6–7 days −11.19* −12.97* −2.70* −1.88 −0.48 −0.29 0.05 −0.03 −0.04 0.00
8+ days −41.46* −42.99* −10.62* −10.09* −0.55 −0.51 −0.07 −0.11* 0.01 −0.01
High humidity −8.70* −11.80* −2.10 −4.56* 0.35 0.28 −0.03 −0.02 −0.06 −0.05
High temperature −13.22* −7.64* −5.91* −5.10* 0.07 −0.27 0.07* 0.01 0.05 −0.04
VBS 0.80* 0.59* 0.63* 0.84* 0.01*
Intercept 301.07* 146.24* 68.44* 34.91* 4.10* 1.70* 1.35* 0.43* 5.57* 4.21*
N 3110 3109 3060 3060 3158 3156 3149 3149 2857 1874
R2 0.13 0.39 0.06 0.36 0.02 0.35 0.04 0.78 0.01 0.41
*P < .05.; Note: Model 1, effect on DBS value; Model 2, effect on DBS value adjusted by VBS.
Abbreviations: CRP, C-reactive protein; DBS, dried blood spot; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; VBS, venous blood sample.
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substantial for HDL cholesterol (6.79 or 34% of a SD), CRP
(1.26 or 27% of a SD), and cystatin C (0.20 or 40% of a SD).
None of the other quality factors was significantly
associated with the CRP DBS value except the VBS value.
The HbA1c value was also not significantly affected by
these factors: multiple drops are associated with higher
values whereas longer shipping time, 3-5 days, appears to
increase the value. Cystatin C values also appear little
affected by additional factors: there is a small but signifi-
cant increase in value on hot days and a decrease for a
shipping time of 8+ days. For these three analytes, only a
small portion of the variance is explained by these condi-
tions: 2% for CRP, 4% for cystatin C, and 1% for HbA1c.
Total and HDL cholesterol values based on DBS were
fairly strongly affected by the number days they were in tran-
sit before arrival at the lab and weather conditions (Table 3).
Shipping of 6 to 7 days resulted in a drop of 11.19 mg/dL in
the value of total cholesterol and 2.70 mg/dL in HDL choles-
terol. About 10% of the sample experienced shipping time of
8 days or more and this was linked to total cholesterol
41 mg/dL lower andHDL cholesterol 11 mg/dL lower than if
shipping had been accomplished in 2 or fewer days. Both
high temperature and high humidity were linked to lower
values of DBS total andHDL cholesterol.
4 | DISCUSSION
This study examined how factors related to DBS collection,
shipping, and environment conditions influence the validity
of DBS assays in a large, geographically diverse population
sample. While DBS is a popular method for collecting bio-
marker data in large surveys, our general conclusion is that
this method of collecting blood can be potentially vulnerable
to collection method and conditions. We can draw several
specific conclusions from our work. First, the effect of collec-
tion, shipping, and environmental factors on DBS samples
varies by analyte. Stability needs to be evaluated for each ana-
lyte of interest as the biochemistry of different analytes is
likely to produce a variety of patterns of stability. Cholesterol
measures in particular are sensitive to multiple influences
including quality of DBS cards, spots, shipping time, and
weather. Adverse circumstances generally reduce the values
of the analytes. Cholesterol assays will have questionable
validity where spots are small, shipping time is long and they
are exposed to heat and humidity. On the other hand, CRP,
cystatin C, and HbA1c were relatively insensitive to shipping
andweather.
Second, small spots are a problem which should be
avoided as they lower the values of all DBS measures
examined here. Instructions to avoid small spots need to
be reinforced with sample collectors. In addition, sample
spots should be coded upon receipt so an adjustment for
small spots can be made. The overall quality of the cards
and the use of a smeared spot seemed to have little effect
on the resulting DBS values. Our third conclusion is that
weather conditions do not generally have significant
effects on these assays; with the exception of cholesterol.
The results of this study suggested the importance of
documenting information on the quality of DBS spots as well
as shipping time and conditions. While it is important to
emphasize a protocol to minimize the effect of these factors,
there are circumstances when conditions are not controlla-
ble, and having information on these factors can be used for
adjustments to assay values or included in analytic models.
We should note that the inclusion of what we considered the
gold standard, VBS value, did not change our results signifi-
cantly meaning that adjustments could be made without this
value. We also reiterate that the fact that there was a two-
month average time difference between the collection of the
DBS and the collection of blood for VBSwas not ideal.
This analysis is based on blood spots that were being col-
lected for the sixth time in the HRS. Other studies may have
similar, or even worse, problems with card and spot qualities.
Continued use of the valuable DBS technology requires more
validity and quality testing for other assays.
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